Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HEPSERA: 55 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
55
Total FAERS Reports
2 (3.6%)
Deaths Reported
23
Hospitalizations
55
As Primary/Secondary Suspect
5
Disabilities

First Report: 200505 · Latest Report: 201404

What Are the Most Common HEPSERA Side Effects?

#1 Most Reported
Osteomalacia
15 reports (27.3%)
#2 Most Reported
Hypophosphataemia
14 reports (25.5%)
#3 Most Reported
Fanconi syndrome acquired
11 reports (20.0%)

All HEPSERA Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Osteomalacia 15 27.3% 1 10
Hypophosphataemia 14 25.5% 1 8
Fanconi syndrome acquired 11 20.0% 1 4
Drug resistance 10 18.2% 1 2
Hepatitis b dna increased 10 18.2% 0 1
Arthralgia 9 16.4% 1 5
Blood phosphorus decreased 9 16.4% 0 4
Back pain 8 14.6% 0 5
Drug ineffective 8 14.6% 0 0
Bone pain 7 12.7% 0 4
Renal impairment 7 12.7% 0 2
Pain 6 10.9% 0 4
Pain in extremity 6 10.9% 0 2
Condition aggravated 5 9.1% 0 3
Muscular weakness 5 9.1% 0 4
Nephrolithiasis 5 9.1% 0 1
Osteoporosis 5 9.1% 0 4
Proteinuria 5 9.1% 0 0
Renal tubular disorder 5 9.1% 0 2

Who Reports HEPSERA Side Effects? Age & Gender Data

Average age: 49.9 years. Most reports from: CN. View detailed demographics →

Is HEPSERA Getting Safer? Reports by Year

YearReportsDeathsHosp.
2005 1 0 0
2006 1 0 1
2007 1 1 1
2008 1 0 1
2009 3 0 0
2010 2 0 2
2011 4 1 1
2012 6 0 3
2013 17 0 9
2014 3 0 0

View full timeline →

What Is HEPSERA Used For?

IndicationReports
Hepatitis b 26
Chronic hepatitis b 19

Official FDA Label for HEPSERA

Official prescribing information from the FDA-approved drug label.